Welcome to LookChem.com Sign In|Join Free
  • or
4-(1H-pyrazol-5-yl)phenol is a phenolic compound with the molecular formula C10H8N2O, derived from the pyrazole structure, featuring a pyrazole ring with a phenyl group attached at the 4-position. This versatile chemical compound possesses biological activities such as antioxidant, anti-inflammatory, and antitumor properties.

68535-53-5

Post Buying Request

68535-53-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

68535-53-5 Usage

Uses

Used in Pharmaceutical Industry:
4-(1H-pyrazol-5-yl)phenol is used as a pharmaceutical compound for its demonstrated biological activities, including antioxidant, anti-inflammatory, and antitumor properties. Its potential applications in medicine make it a valuable candidate for the development of new therapeutic agents.
Used in Organic Synthesis:
4-(1H-pyrazol-5-yl)phenol is used as a synthetic building block in the creation of various organic compounds. Its unique structure allows it to be a key component in the synthesis of a wide range of chemical products.
Used in Industrial Applications:
4-(1H-pyrazol-5-yl)phenol may have potential industrial applications due to its versatile nature and the possibility of being integrated into different manufacturing processes or products. Its specific uses in industry would depend on the requirements and innovations within various sectors.

Check Digit Verification of cas no

The CAS Registry Mumber 68535-53-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,8,5,3 and 5 respectively; the second part has 2 digits, 5 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 68535-53:
(7*6)+(6*8)+(5*5)+(4*3)+(3*5)+(2*5)+(1*3)=155
155 % 10 = 5
So 68535-53-5 is a valid CAS Registry Number.

68535-53-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-(1,2-dihydropyrazol-3-ylidene)cyclohexa-2,5-dien-1-one

1.2 Other means of identification

Product number -
Other names 4-(1(2)H-pyrazol-3-yl)-phenol

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:68535-53-5 SDS

68535-53-5Relevant academic research and scientific papers

Synthesis of aryl-substituted or aryl-fused N-hydroxyethyl and N-hydroxymethypyrazole derivatives as potential ligands for the estrogen receptor

Allahyari-Devin, Maryam,Abedi, Behnam,Navidpour, Latifeh,Shafiee, Abbas

, p. 43 - 53 (2013/02/25)

A new series of N-hydroxyethylpyrazole (12a-f) and N-hydroxymethylpyrazole derivatives (15a-f) were designed for their estrogenic activities, having a 11.0 ± 0.5 A distance between their two hydroxyl groups, aliphatic-OH and phenolic-OH similar to 17β-estradiol (E2) as an endogenous hormone. To synthesize the title compounds, the key intermediate 1,3-dicarbonyl derivatives (2 and 8), were treated with hydrazine hydrate to produce the pyrazole ring 5 and 9. Further hydroxyalkylation of the latter produced the title pyrazoles. The position of hydroxyethyl or hydroxymethyl substituents in the products was determined through 2D NOE NMR spectroscopy.

Synthesis and analgesic-antiinflammatory activity of some 4- and 5-substituted heteroarylsalicylic acids

Jones,Fordice,Greenwald,Hannah,Jacobs,Ruyle,Walford,Shen

, p. 1100 - 1104 (2007/10/05)

We have made a series of 4- and 5-aryl- and 4- and 5-heteroarylsalicylic acid derivatives with the objective of reducing gastric irritation and increasing potency. Here we describe a series of 4- and 5-heterocyclic salicylic acids and their antiinflammatory-analgesic potencies measured in comparison to aspirin. An improvement of the therapeutic index over aspirin of 100 was achieved; however, the heterocyclic salicylic acids lacked antipyretic activity. Some physicochemical parameters which may bear on the antiinflammatory activity of these compounds are discussed.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 68535-53-5